Clicky

A year on, Delhi riot victims struggle to cope with depression, nightmares & livelihood loss

(From left) Images of five-year-old Alisha Khan, whose father was a riot victim, Monu Kumar, who also lost his father in the violence, Delhi Police head constable Ratan Lal, who was shot dead, and Mohammed Wakeel, who lost his vision | ThePrint photos Text Size: A- A+ New Delhi: Around this time […]

A year on, Delhi riot victims struggle to cope with depression, nightmares & livelihood loss Read More »

Mercy Health Adds New Depression Treatment to Suite of Services – Business Journal Daily

YOUNGSTOWN, Ohio – Mercy Health-Youngstown has added a new tool to its suite of behavioral health services: transcranial magnetic stimulation. The technology, used to help with the treatment of depression, delivers magnetic pulses to the parts of the brain responsible for mood control. Patients having the procedure done will sit in a chair while medical

Mercy Health Adds New Depression Treatment to Suite of Services – Business Journal Daily Read More »

Depressed adolescents more physiologically reactive to acute social media use vs. controls

February 22, 2021 1 min read Source/Disclosures Disclosures: One study author reports several financial disclosures. The other authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email

Depressed adolescents more physiologically reactive to acute social media use vs. controls Read More »

Mindfulness can be a powerful key in reducing depressive and anxious thoughts and feelings

WAUSAU, Wis. (WSAW) – The COVID pandemic has forced any already existing mental health crisis to the forefront. And because resources for improving our mental health are limited — like going to the gym and being social overall, there’s something you can practice in the comfort of your own home, or any time for that

Mindfulness can be a powerful key in reducing depressive and anxious thoughts and feelings Read More »

Lumateperone sNDAs Submitted for Bipolar Depression Indication

Intra-Cellular Therapies, Inc has submitted supplemental New Drug Applications (sNDAs) to the Food and Drug Administration (FDA) for the use of lumateperone in the treatment of depressive episodes associated with bipolar I or II disorder, both as monotherapy and as adjunctive therapy. The sNDA submissions are supported by data from 2 global randomized, double-blind, placebo-controlled

Lumateperone sNDAs Submitted for Bipolar Depression Indication Read More »

Almost half of individuals with COVID-19 may have moderate to severe depressive symptoms

February 22, 2021 2 min read Source/Disclosures Disclosures: One study author reports various financial disclosures. The other authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an

Almost half of individuals with COVID-19 may have moderate to severe depressive symptoms Read More »